1.10HKD
603.35 MHKD
5.96 BHKD
69.60 M
About SHANGHAI HENLIUS BIOTECH INC
Sector
CEO
Jun Zhu
Headquarters
Shanghai
Website
Employees (FY)
3.64 K
Founded
2010
ISIN
CNE100003N76
FIGI
BBG00Q3NTQ54
Shanghai Henlius Biotech, Inc. engages in the production and sale of monoclonal antibody (mAb) drugs and the provision of related consultation and technical services, and the transfer of its own technology. It operates through the Mainland China and Overseas geographical segments. The company was founded by Wei Dong Jiang and Shi Gao Liu in 2010 and is headquartered in Shanghai, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 2696 is 14.66 HKD — it has increased by 0.69% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange SHANGHAI HENLIUS BIOTECH INC stocks are traded under the ticker 2696.
2696 stock is 4.52% volatile and has beta coefficient of 1.33. Check out the list of the most volatile stocks — is SHANGHAI HENLIUS BIOTECH INC there?
One year price forecast for SHANGHAI HENLIUS BIOTECH INC has a max estimate of 25.00 HKD and a min estimate of 15.64 HKD.
Yes, you can track SHANGHAI HENLIUS BIOTECH INC financials in yearly and quarterly reports right on TradingView.
2696 stock has risen by 0.41% compared to the previous week, the month change is a 0.27% rise, over the last year SHANGHAI HENLIUS BIOTECH INC has showed a 3.97% increase.
2696 net income for the last quarter is 149.42 M HKD, while the quarter before that showed 181.19 M HKD of net income which accounts for −17.53% change. Track more SHANGHAI HENLIUS BIOTECH INC financial stats to get the full picture.
Today SHANGHAI HENLIUS BIOTECH INC has the market capitalization of 7.91 B, it has increased by 4.90% over the last week.
No, 2696 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 2696 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI HENLIUS BIOTECH INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 3.64 K employees. See our rating of the largest employees — is SHANGHAI HENLIUS BIOTECH INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI HENLIUS BIOTECH INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI HENLIUS BIOTECH INC stock shows the neutral signal. See more of SHANGHAI HENLIUS BIOTECH INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SHANGHAI HENLIUS BIOTECH INC future price: according to them, 2696 price has a max estimate of 25.00 HKD and a min estimate of 15.64 HKD. Read a more detailed SHANGHAI HENLIUS BIOTECH INC forecast: see what analysts think of SHANGHAI HENLIUS BIOTECH INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHANGHAI HENLIUS BIOTECH INC EBITDA is 1.09 B HKD, and current EBITDA margin is 18.37%. See more stats in SHANGHAI HENLIUS BIOTECH INC financial statements.